Table 1 Proposal for a real life distribution of Italian health care resources for respiratory allergic diseases
I level | II level | III level | Availability, for the National Health Care Service | Availability, for habitants (×1000) | |
|---|---|---|---|---|---|
Consultant for allergy | √ | TS and HS I level | 80–150 | ||
Skin prick test (inhalants, foods, latex) | √ | TS and HS I level | 80–150 | ||
Spirometry F/V curve | √ | TS and HS I level | 80–150 | ||
Reversibility test | √ | TS and HS I level | 80–150 | ||
Total IgE | √ | HS I level | 150–300 | ||
Specific IgE, panel for inhalants | √ | HS I level | 150–300 | ||
Specific IgE, panel for foods | √ | HS I level | 150–300 | ||
Component resolved diagnosis | √ | HS I–II level | 600–1200 | ||
Spirometry, lung volumesa | √ | HS I level | 150–300 | ||
Spirometry, DLCOa | √ | HS I level | 150–300 | ||
Methacholine–challengea | √ | HS I level | 150–300 | ||
Mannitol challengea | √ | HS I–II level | 300–600 | ||
Exhaled nitric oxide (FeNO) measurement | √ | HS I level | 150–300 | ||
Exercise challengea | √ | HS I level | 150–300 | ||
CPETa | √ | HS I–II level | 300–600 | ||
Severe asthma centerb | √ | HS I–II level | 300–600 | ||
HymenopteraVIT centerb | √ | HS I–II level | 300–600 | ||
Pharmacoallergy centerb | √ | HS II level | 600–1200 |